NeOnc Technologies Holdings, Inc.

US$3.49As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:NTHIHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE —
Biotechnology
Beta (5Y) —
PE TTM —
TSR TTM (64.39%)
Mkt cap US$86.75M
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
$4.46
27.67%
(35.34%)
Hold 0|1|7|3|12
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.07
0.07
0.07
0.06
9.26%
9.68%
9.88%
(2.59%)
Revenue$M
7.321
7.509
7.432
7.765
7.13%
12.95%
8.81%
7.89%
Peers (US$86.75M)
Cap (US$)
PE
87.97M
—
84.80M
3.385x
Capital
TTM
5Y
10Y
Leveragex
0.617
(0.383)
(0.265)
EBIT/Intx
0.402
0.170
0.178
Own earn%
38.94
91.70
70.81
Sh yield%
28.81
8.75
11.24
Owners
Insiders/Inst%
5.96
66.46
Short interest%
5.29
SBC / revenue%
2.36
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
5
Op margin range%
17–31
$1 testx
—
Incr. ROIC%
3